This mechanism and the key role of TNF/IL-23/IL-17 signal axis in psoriasis was confirmed by the effectiveness of therapies which were anti-IL-12, anti-IL-17, anti-IL-23 and anti-TNFα [40,58] or their receptors [59]. This evidence concerns the gene IL17A and psoriasis.